SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 124 filers reported holding SAGE THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is 2.96 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $38,913 | +387.3% | 827,577 | +334.8% | 0.13% | +362.1% |
Q1 2023 | $7,986 | -100.0% | 190,333 | -14.3% | 0.03% | -72.6% |
Q3 2019 | $31,144,000 | -64.5% | 221,994 | -53.6% | 0.11% | -62.8% |
Q2 2019 | $87,629,000 | -11.2% | 478,611 | -22.9% | 0.28% | -13.4% |
Q1 2019 | $98,717,000 | +706.6% | 620,668 | +385.8% | 0.33% | +631.1% |
Q4 2018 | $12,238,000 | -71.2% | 127,758 | -57.5% | 0.04% | -61.9% |
Q3 2018 | $42,455,000 | -49.9% | 300,565 | -44.4% | 0.12% | -52.2% |
Q2 2018 | $84,664,000 | +12.4% | 540,878 | +15.6% | 0.25% | +10.3% |
Q1 2018 | $75,357,000 | -31.9% | 467,854 | -30.3% | 0.22% | -28.9% |
Q4 2017 | $110,609,000 | +544.0% | 671,535 | +143.6% | 0.32% | +530.0% |
Q3 2017 | $17,174,000 | -40.4% | 275,665 | -23.8% | 0.05% | -41.9% |
Q2 2017 | $28,805,000 | -41.6% | 361,688 | -47.9% | 0.09% | -41.9% |
Q1 2017 | $49,359,000 | +68.7% | 694,506 | +21.2% | 0.15% | +66.3% |
Q4 2016 | $29,260,000 | -6.4% | 573,054 | -15.6% | 0.09% | -6.3% |
Q3 2016 | $31,270,000 | +43.6% | 679,048 | -6.1% | 0.10% | +39.7% |
Q2 2016 | $21,778,000 | +27.8% | 722,800 | +36.0% | 0.07% | +25.9% |
Q1 2016 | $17,037,000 | -73.3% | 531,404 | -51.5% | 0.05% | -71.9% |
Q4 2015 | $63,855,000 | +479.5% | 1,095,283 | +320.7% | 0.19% | +481.8% |
Q3 2015 | $11,019,000 | -86.1% | 260,368 | -76.0% | 0.03% | -84.2% |
Q2 2015 | $79,359,000 | +778.3% | 1,087,109 | +504.3% | 0.21% | +808.7% |
Q1 2015 | $9,036,000 | +128.1% | 179,897 | +66.2% | 0.02% | +130.0% |
Q4 2014 | $3,961,000 | – | 108,226 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DAFNA Capital Management LLC | 99,306 | $14,027,000 | 5.76% |
Casdin Capital, LLC | 312,000 | $44,070,000 | 5.36% |
Palo Alto Investors LP | 840,372 | $118,703,000 | 4.80% |
BB BIOTECH AG | 1,071,373 | $151,331,000 | 4.00% |
TRV GP II, LLC | 37,362 | $5,277,000 | 3.10% |
Eversept Partners, LP | 43,621 | $6,161,466 | 2.70% |
RA Capital Management | 350,933 | $49,569,000 | 2.65% |
Eventide Asset Management | 494,000 | $69,778,000 | 2.56% |
OAK RIDGE INVESTMENTS LLC | 241,099 | $34,055,000 | 1.88% |
SUFFOLK CAPITAL MANAGEMENT LLC | 93,000 | $13,136,000 | 1.87% |